Sensei Biotherapeutics, Inc. SNSE 深 滬
已收盤 05-08 16:00:00 美东时间
23.40
-0.360
-1.52%
華盛通- 最 高25.235
- 今 開23.76
- 成交量 1.62万股
- 最 低 22.75
- 昨 收 23.76
- 總市值 3138.27万
- 52周最高 36.76
- 市盈率 靜 --
- 換手率 1.21%
- 52周最低 5.25
- 委 比 -88.24%
- 總股本 134.11万
- 歷史最高 530.00
- 量 比 0.52
- 振 幅 10.46%
- 歷史最低 5.00
- 每 手 1
- 風險率 9.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sensei Biotherapeutics Says First Patient Dosed In Study FTH-PIK-101, Phase 1b/2 Trial Of PIKTOR In Patients With HR+/HER2- Advanced Breast Cancer
PIKTOR is an investigational all-oral, multi-node inhibitor targeting escape routes in the PI3K/AKT/mTOR pathway that single-node inhibitors leave openSensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical-stage
05-05 19:34
5月医疗保健股多空榜：Sensei及KalVista空头比例居前
随着4月结束，市值20亿美元以下的小型医疗保健股空头头寸显著增加，显示市场对这类高波动性股票的看空情绪升温。 根据最新数据，5月初医疗保健板块空头比例最...
05-05 03:24
Sensei Biotherapeutics Announces Leadership and Board Transitions
Sensei Biotherapeutics ( ($SNSE) ) just unveiled an update. On April 10, 2026, ...
04-17 04:51
Sensei Biotherapeutics to present at Needham Virtual Healthcare Conference
Sensei Biotherapeutics to present at Needham Virtual Healthcare Conference Sensei Biotherapeutics management will present at Needham 25th Annual Virtual Healthcare Conference on April 16, 2026 at 12:45 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative ar
04-09 19:34
BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update March 30 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nBwjmfmya Further company coverag
03-30 20:01
Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate
Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(3.74) per share which beat the analyst consensus estimate of $(4.11) by 9 percent. This is a 39.68 percent increase over losses of $(6.20) per share
03-30 19:50
Sensei Biotherapeutics GAAP EPS of -$16.72
Sensei Biotherapeutics press release (SNSE): FY GAAP EPS of -$16.72. Cash, cash equivalents and marketable securities were $21.2 million as of December 31, 2025 as compared to $41.3 million as of Dece...
03-30 19:37
Sensei Biotherapeutics FY25 net loss narrows 30% to $21.1 million
Sensei Biotherapeutics FY25 net loss narrows 30% to $21.1 million Sensei Biotherapeutics posted a net loss of $21.1 million. Operating loss narrowed to $22.3 million as operating expenses fell to $22.3 million. R&D expense dropped to $11 million due to reduced costs across personnel, facilities, lab
03-30 19:31
BRIEF-Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BRIEF-Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 17 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nBw9sZpCla Further company coverage: SNSE.O (
03-17 18:17
